2019 Visionary Awards
Date and Time
Thursday Nov 21, 2019
6:00 PM - 9:00 PM EST
Location
Royal Sonesta Hotel
40 Edwin H Land Blvd, Cambridge, MA 02142
Fees/Admission
Single Ticket - $150
Bundle of 10 - $1,400
2019 Visionary Awards
Description
The Cambridge Chamber of Commerce 2019 Visionary Awards - Celebrating innovation, discovery & visionaries in our community!
Join us for an evening of celebration as we recognize innovators from the business, institutional, and nonprofit communities who are truly making a difference in Cambridge and beyond!
2019 Visionary Award Recipients
Alnylam Pharmaceuticals for leading the way in a new class of innovative medicines using RNA interference to transform the lives of people afflicted with rare genetic, cardio-metabolic, and hepatic infectious diseases.
Biogen and the Biogen Foundation for the creation of STAR a Coordinated ?Ecosystem? of local nonprofits aimed at helping Cambridge & Somerville public school students pursue STEM education.
Ed Fritsch and his dedicated team at ACIR (Accelerating Cancer Immunotherapy Research) for helping researchers stay on top of new literature in the fast-moving cancer immunotherapy field by fostering researcher?s productivity to bring us closer to curing this deadly disease.
The Foundry Consortium for their collaborative effort to create a self-sustaining center for Arts + STEM for the diverse communities of Cambridge.
Michael Monestime and the Central Square Commercial Property owners for their advocacy, collaboration and vision to make the Central Square Business Improvement District (BID) a reality.
Philips Healthcare for their development of the Precision Infection Prevention software: IntelliSpace Epidemiology Information System. This solution helps hospitals stop healthcare associated infections with clinical informatics and pathogen genomics
Biogen and the Biogen Foundation for the creation of STAR a Coordinated ?Ecosystem? of local nonprofits aimed at helping Cambridge & Somerville public school students pursue STEM education.
Ed Fritsch and his dedicated team at ACIR (Accelerating Cancer Immunotherapy Research) for helping researchers stay on top of new literature in the fast-moving cancer immunotherapy field by fostering researcher?s productivity to bring us closer to curing this deadly disease.
The Foundry Consortium for their collaborative effort to create a self-sustaining center for Arts + STEM for the diverse communities of Cambridge.
Michael Monestime and the Central Square Commercial Property owners for their advocacy, collaboration and vision to make the Central Square Business Improvement District (BID) a reality.
Philips Healthcare for their development of the Precision Infection Prevention software: IntelliSpace Epidemiology Information System. This solution helps hospitals stop healthcare associated infections with clinical informatics and pathogen genomics
Rubius Therapeutics for their development of the new class of cellular medicines, Red Cell Therapeutics. These Life-changing cellular therapies are in development to treat metabolic disorders, cancer, and autoimmune diseases.
Sage Therapeutics for developing and bringing to market the first and only medicine specifically approved to treat Postpartum Depression (PPD), a common complication of pregnancy that affects more than 400,000 women in the U.S. annually.
Sage Therapeutics for developing and bringing to market the first and only medicine specifically approved to treat Postpartum Depression (PPD), a common complication of pregnancy that affects more than 400,000 women in the U.S. annually.
Thank you to our Sponsors!
Platinum
Gold
Silver
Bronze
Bar Sponsor
